MMP2 Polyclonal Antibody PE-Cy7 Conjugated
Cat# MBS9462169-5x0,1mL
Size : 5x0.1mL
Brand : MyBiosource
MMP2 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9462169MBS9462169 is an antibody targeting MMP2. Also known as MMP2 Polyclonal Antibody PE-Cy7 Conjugated. Reactive in Human, Mouse, Rat. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
MMP2, Polyclonal Antibody
Full Product Name
MMP2 Polyclonal Antibody PE-Cy7 Conjugated
Product Gene Name
anti-MMP2 antibody
Product Synonym Names
MMP2
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Mouse, Rat
Form/Format
0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Purity/Purification
affinity purified by Protein A
Preparation and Storage
Store at -20 degree C for one year. Avoid repeated freeze/thaw cycles.
Shipped at 4 degree C.
Shipped at 4 degree C.
Applications Tested/Suitable for anti-MMP2 antibody
Flow Cytometry (FC/FACS), Immunofluorescence (IF)
Application Notes for anti-MMP2 antibody
FC/FACS: 1:50-200
IF: 1:50-200
IF: 1:50-200
Other Notes
Small volumes of anti-MMP2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for MMP2. It may not necessarily be applicable to this product.
NCBI Official Full Name
72 kDa type IV collagenase isoform b
NCBI Official Synonym Full Names
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
NCBI Official Symbol
MMP2
NCBI Official Synonym Symbols
CLG4; MONA; CLG4A; TBE-1; MMP-II
UniProt Protein Name
72 kDa type IV collagenase
UniProt Synonym Protein Names
72 kDa gelatinase; Gelatinase A; Matrix metalloproteinase-2; MMP-2; TBE-1
Protein Family
72 kDa type IV collagenase
UniProt Gene Name
MMP2
UniProt Synonym Gene Names
CLG4A; MMP-2
UniProt Entry Name
MMP2_HUMAN
NCBI Protein Information
72 kDa type IV collagenase; MMP-2; gelatinase A; 72 kDa gelatinase; collagenase type IV-A; neutrophil gelatinase; matrix metalloproteinase-2; matrix metalloproteinase-II
NCBI Summary for MMP2
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. This gene encodes an enzyme which degrades type IV collagen, the major structural component of basement membranes. The enzyme plays a role in endometrial menstrual breakdown, regulation of vascularization and the inflammatory response. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for MMP2
MMP2: Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Interacts (via the C-terminal hemopexin-like domains- containing region) with the integrin alpha-V/beta-3; the interaction promotes vascular invasion in angiogenic vessels and melamoma cells. Interacts (via the C-terminal PEX domain) with TIMP2 (via the C-terminal); the interaction inhibits the degradation activity. Interacts with GSK3B. Aspirin appears to inhibit expression. Produced by normal skin fibroblasts. PEX is expressed in a number of tumors including gliomas, breast and prostate. Inhibited by histatin-3 1/24 (histatin-5). Belongs to the peptidase M10A family.
Protein type: Cell development/differentiation; Apoptosis; Motility/polarity/chemotaxis; Protease; Secreted, signal peptide; EC 3.4.24.24; Secreted
Chromosomal Location of Human Ortholog: 16q12.2
Cellular Component: proteinaceous extracellular matrix; extracellular space; sarcomere; mitochondrion; extracellular region; plasma membrane; nucleus
Molecular Function: protein binding; zinc ion binding; metalloendopeptidase activity; serine-type endopeptidase activity
Biological Process: axon guidance; extracellular matrix organization and biogenesis; intramembranous ossification; proteolysis; blood vessel maturation; collagen catabolic process; extracellular matrix disassembly; cellular protein metabolic process; positive regulation of innate immune response; response to hypoxia; ephrin receptor signaling pathway; angiogenesis; embryo implantation
Disease: Multicentric Osteolysis, Nodulosis, And Arthropathy
Show more Protein type: Cell development/differentiation; Apoptosis; Motility/polarity/chemotaxis; Protease; Secreted, signal peptide; EC 3.4.24.24; Secreted
Chromosomal Location of Human Ortholog: 16q12.2
Cellular Component: proteinaceous extracellular matrix; extracellular space; sarcomere; mitochondrion; extracellular region; plasma membrane; nucleus
Molecular Function: protein binding; zinc ion binding; metalloendopeptidase activity; serine-type endopeptidase activity
Biological Process: axon guidance; extracellular matrix organization and biogenesis; intramembranous ossification; proteolysis; blood vessel maturation; collagen catabolic process; extracellular matrix disassembly; cellular protein metabolic process; positive regulation of innate immune response; response to hypoxia; ephrin receptor signaling pathway; angiogenesis; embryo implantation
Disease: Multicentric Osteolysis, Nodulosis, And Arthropathy
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-MMP2 antibody
| Reference Product | PubMed Publications |
|---|---|
| TIMP2 antibody | >222 publications with MMP2 and TIMP2 |
| TIMP1 antibody | >193 publications with MMP2 and TIMP1 |
| MMP14 antibody | >118 publications with MMP2 and MMP14 |
| TGFB1 antibody | >107 publications with MMP2 and TGFB1 |
| TIMP3 antibody | >59 publications with MMP2 and TIMP3 |
| COL1A1 antibody | >21 publications with MMP2 and COL1A1 |
| CXCL12 antibody | >16 publications with MMP2 and CXCL12 |
| TIMP4 antibody | >15 publications with MMP2 and TIMP4 |
| THBS1 antibody | >14 publications with MMP2 and THBS1 |
| FGFR1 antibody | >8 publications with MMP2 and FGFR1 |
Pathways associated with anti-MMP2 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| AGE/RAGE Pathway antibodies | AGE/RAGE Pathway Diagram |
| ATF-2 Transcription Factor Network Pathway antibodies | ATF-2 Transcription Factor Network Pathway Diagram |
| Activation Of Matrix Metalloproteinases Pathway antibodies | Activation Of Matrix Metalloproteinases Pathway Diagram |
| Angiopoietin Receptor Tie2-mediated Signaling Pathway antibodies | Angiopoietin Receptor Tie2-mediated Signaling Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Degradation Of Collagen Pathway antibodies | Degradation Of Collagen Pathway Diagram |
| Degradation Of Collagen Pathway antibodies | Degradation Of Collagen Pathway Diagram |
| Degradation Of The Extracellular Matrix Pathway antibodies | Degradation Of The Extracellular Matrix Pathway Diagram |
| Degradation Of The Extracellular Matrix Pathway antibodies | Degradation Of The Extracellular Matrix Pathway Diagram |
Diseases associated with anti-MMP2 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >884 publications with MMP2 and Neoplasms |
| Neoplasm Invasiveness Antibodies | >373 publications with MMP2 and Neoplasm Invasiveness |
| Neoplasm Metastasis Antibodies | >296 publications with MMP2 and Neoplasm Metastasis |
| Inflammation Antibodies | >214 publications with MMP2 and Inflammation |
| Heart Diseases Antibodies | >150 publications with MMP2 and Heart Diseases |
| Necrosis Antibodies | >142 publications with MMP2 and Necrosis |
| Breast Neoplasms Antibodies | >121 publications with MMP2 and Breast Neoplasms |
| Bone Diseases Antibodies | >79 publications with MMP2 and Bone Diseases |
| Aortic Diseases Antibodies | >73 publications with MMP2 and Aortic Diseases |
| Colorectal Neoplasms Antibodies | >69 publications with MMP2 and Colorectal Neoplasms |
Organs/Tissues associated with anti-MMP2 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Vascular Antibodies | >523 publications with MMP2 and Vascular |
| Blood Antibodies | >478 publications with MMP2 and Blood |
| Muscle Antibodies | >275 publications with MMP2 and Muscle |
| Lung Antibodies | >221 publications with MMP2 and Lung |
| Bone Antibodies | >183 publications with MMP2 and Bone |
| Liver Antibodies | >178 publications with MMP2 and Liver |
| Heart Antibodies | >167 publications with MMP2 and Heart |
| Brain Antibodies | >153 publications with MMP2 and Brain |
| Connective Tissue Antibodies | >110 publications with MMP2 and Connective Tissue |
| Kidney Antibodies | >107 publications with MMP2 and Kidney |


